MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 13.12.2025
Galmed Pharmaceuticals Ltd. Operativer Cashflow 2011-2025 | GLMD
Operativer Cashflow Jährlich Galmed Pharmaceuticals Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.88 M | -6.14 M | -18.5 M | -32.9 M | -26.3 M | -14.9 M | -9.02 M | -12.1 M | -12.1 M | -8.47 M | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -5.88 M | -32.9 M | -14.6 M |
Operativer Cashflow anderer Aktien in der Pharmaeinzelhändler
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Arbutus Biopharma Corporation
ABUS
|
-85.9 M | $ 4.86 | 3.08 % | $ 807 M |  Canada |
 |
MorphoSys AG
MOR
|
-481 M | - | 2.43 % | $ 254 M |  Germany |
 |
Aclaris Therapeutics
ACRS
|
-20.1 M | $ 3.22 | -1.08 % | $ 249 M |  USA |
 |
AlloVir
ALVR
|
-67.7 M | - | 4.14 % | $ 49.1 M | USA |
 |
Aptevo Therapeutics
APVO
|
-23.8 M | $ 1.05 | -7.08 % | $ 290 K | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-7.64 M | $ 0.27 | -4.88 % | $ 588 M |  Israel |
 |
Catalyst Biosciences
CBIO
|
25.9 M | $ 13.58 | -3.62 % | $ 894 M | USA |
 |
Ascendis Pharma A/S
ASND
|
-418 M | $ 216.09 | -1.96 % | $ 5 B |  Danmark |
 |
Midatech Pharma plc
MTP
|
-6.01 M | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alterity Therapeutics Limited
ATHE
|
-12.3 M | $ 3.14 | -4.15 % | $ 7.55 B |  Australia |
 |
Celldex Therapeutics
CLDX
|
-158 M | $ 27.1 | -1.51 % | $ 1.75 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
198 M | $ 88.16 | 0.19 % | $ 9.1 B | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
240 M | $ 24.27 | 2.75 % | $ 2.87 B | USA |
 |
Biophytis SA
BPTS
|
-23.8 M | - | -13.47 % | $ 169 M |  France |
 |
CureVac N.V.
CVAC
|
-733 M | $ 5.02 | -0.59 % | $ 934 M | Germany |
 |
BioVie
BIVI
|
-19 M | $ 1.4 | -3.45 % | $ 2.07 M | USA |
 |
ARCA biopharma
ABIO
|
-57.8 M | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
-14.9 M | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
-141 M | - | -15.15 % | $ 60.3 M | Britain |
 |
BioNTech SE
BNTX
|
890 M | $ 93.87 | -0.99 % | $ 27.2 B | Germany |
 |
Aeglea BioTherapeutics
AGLE
|
-157 M | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
-108 M | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-43.8 M | - | - | $ 2.17 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
66.5 M | $ 10.8 | - | $ 1.4 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-8.56 M | - | -11.43 % | $ 502 K | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
213 M | $ 26.2 | 3.68 % | $ 1.27 B | USA |
 |
Applied Molecular Transport
AMTI
|
-93.9 M | - | - | $ 10.1 M | USA |
 |
Anika Therapeutics
ANIK
|
-1.79 M | $ 9.57 | 0.1 % | $ 140 M | USA |
 |
Eton Pharmaceuticals
ETON
|
6.82 M | $ 15.96 | -4.42 % | $ 409 M | USA |
 |
Evogene Ltd.
EVGN
|
-24.7 M | $ 1.07 | -0.51 % | $ 27.9 M | Israel |
 |
Exelixis
EXEL
|
700 M | $ 41.43 | 1.35 % | $ 12 B | USA |
 |
Arena Pharmaceuticals
ARNA
|
-452 M | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
-76.2 M | - | 3.77 % | $ 22.4 M | USA |
 |
Acer Therapeutics
ACER
|
-30.3 M | - | 2.71 % | $ 14 M | USA |
 |
Avenue Therapeutics
ATXI
|
-9.03 M | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
-63.2 M | - | 1083.1 % | $ 745 M | USA |
 |
Axon Enterprise
AXON
|
408 M | $ 548.8 | -2.74 % | $ 41.6 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-34.5 M | - | - | $ 7.46 M | Israel |
|
Foghorn Therapeutics
FHTX
|
-100 M | $ 4.36 | -1.8 % | $ 239 M | USA |
 |
Aytu BioScience
AYTU
|
-1.94 M | $ 2.39 | 3.91 % | $ 15 M | USA |
 |
AstraZeneca PLC
AZN
|
5.96 B | $ 91.03 | 1.34 % | $ 96.9 B | Britain |
 |
Acorda Therapeutics
ACOR
|
-14 M | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
-4.34 M | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
181 M | $ 8.85 | -1.72 % | $ 1.45 B | Britain |
 |
BeiGene, Ltd.
BGNE
|
-141 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-831 M | $ 11.36 | -1.47 % | $ 735 M | USA |
 |
Biogen
BIIB
|
2.88 B | $ 174.34 | 0.14 % | $ 25.4 B | USA |